Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB2 | P05107 | 3/20 | 0.57 |
| ▸ | ICAM1 | P05362 | 3/20 | 0.57 |
| ▸ | ITGAL | P20701 | 3/20 | 0.57 |
| ▸ | REN | P00797 | 4/20 | 0.51 |
| ▸ | CA1 | P00915 | 3/20 | 0.51 |
| ▸ | CA2 | P00918 | 3/20 | 0.51 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.49 |
| ▸ | ACE | P12821 | 1/20 | 0.47 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.46 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14028689 | 1.00 | ITGB2 (0.57) | ITGB2ICAM1ITGALRENCA1 | |
| SCHEMBL1133307 | 1.00 | ITGB2 (0.57) | ITGB2ICAM1ITGALRENCA1 | |
| SCHEMBL28684251 | 0.99 | ITGB2 (0.56) | ITGB2ICAM1ITGALRENCA1 | |
| SCHEMBL18878768 | 0.90 | REN (0.49) | ITGB2ICAM1ITGALRENCA1 | |
| SCHEMBL7438987 | 0.89 | ITGB2 (0.54) | ITGB2ICAM1ITGALRENCA1 | |
| SCHEMBL1486141 | 0.89 | REN (0.49) | ITGB2ICAM1ITGALRENHRH3 | |
| SCHEMBL18814494 | 0.89 | REN (0.49) | ITGB2ICAM1ITGALRENHRH3 | |
| SCHEMBL29290115 | 0.88 | REN (0.55) | RENSLC15A2 | |
| SCHEMBL7317825 | 0.88 | REN (0.66) | RENACE | |
| SCHEMBL6806998 | 0.87 | ITGB2 (0.62) | ITGB2ICAM1ITGALCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117720617-A | Synthesis process of acetyl tetrapeptide-3 | 山东济肽生物科技有限公司 | 2024-03-19 | — | — | CN | claimed |
| CN-117720471-A | Preparation method of N-tert-butoxycarbonyl-L-histidine-N-trityl | 成都普康唯新生物科技有限公司 | 2024-03-19 | — | — | CN | claimed |
| CN-115252806-A | Preparation method of nano-drug carrier G5-R with high-efficiency tumor penetration capacity | 浙江大学杭州国际科创中心 | 2022-11-01 | — | — | CN | claimed |
| CN-112791071-A | Polymer micelle drug-loaded composition for aerosol inhalation and preparation method and application thereof | 北京正隆医药研究院有限责任公司 | 2021-05-14 | — | — | CN | claimed |
| CN-104856973-A | Cabazitaxel micelle drug load system and preparation method thereof | SUZHOU LEINA PHARMACEUTICAL RES DEV CO LTD | 2015-08-26 | — | — | CN | claimed |
| CN-102796170-B | Double saturated aliphatic chain alcohol His-Gly-Lys-Asp tetrapeptide esters and preparation method and application thereof | UNIV CAPITAL MEDICAL SCIENCES | 2014-01-29 | — | — | CN | claimed |
| CN-102796171-B | Double saturated aliphatic chain alcohol His-Gly-Glu-Asp tetrapeptide esters and preparation method and application thereof | UNIV CAPITAL MEDICAL SCIENCES | 2014-01-29 | — | — | CN | claimed |
| CN-102796170-A | Double saturated aliphatic chain alcohol His-Gly-Lys-Asp tetrapeptide esters and preparation method and application thereof | UNIV CAPITAL MEDICAL | 2012-11-28 | — | — | CN | claimed |
| CN-102796171-A | Double saturated aliphatic chain alcohol His-Gly-Glu-Asp tetrapeptide esters and preparation method and application thereof | UNIV CAPITAL MEDICAL | 2012-11-28 | — | — | CN | claimed |
| CN-101597291-A | 2-(aminoacyl tryptophyl)-beta-tetrahydro carboline-3-benzyl carboxylate and its production and application | UNIV CAPITAL MEDICAL (CN) | 2009-12-09 | — | — | CN | claimed |
| US-12625431-B2 | EUV resist underlayer film-forming composition | NISSAN CHEMICAL CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| US-20260116857-A1 | INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOFS | PARDES BIOSCIENCES INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-12454771-B2 | Substrates, peptide arrays, and methods | VIBRANT HOLDINGS LLC (US) | 2025-10-28 | — | — | US | disclosed |
| CN-118772440-B | Preparation process and application of slow-release L-carnosine biological hydrogel | 苏州富士莱医药股份有限公司 | 2025-03-11 | — | — | CN | disclosed |
| US-12145911-B2 | Inhibitors of cysteine proteases and methods of use thereof | Pardes Biosciences, Inc. (US) | 2024-11-19 | — | — | US | disclosed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | disclosed |
| US-4757050-A | Urea, amide group-containing | E. R. SQUIBB SONS, INC. (US) | 1988-07-12 | — | — | US | disclosed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | disclosed |
| CN-86105870-A | Band 5-amino-2, the blood vessel tension peptide protoenzyme inhibitor of 5-two replacement-4-hydroxypentanoic acid bases | — | 1987-03-11 | — | — | CN | disclosed |
| EP-0206313-A2 | Chloro-substituted ketone imidazole derivatives | G.D. Searle & Co. (US) | 1986-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260116857-A1 | INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOFS | CTRC, CTRL, CTSL | ITGB2 2812/4885ICAM1 4087/4885ITGAL 2478/4885 |
| US-12625431-B2 | EUV resist underlayer film-forming composition | EEF1A1, ARF1, EMG1 | ITGB2 414/4885ICAM1 799/4885ITGAL 855/4885 |
| US-12145911-B2 | Inhibitors of cysteine proteases and methods of use thereof | CTRL, CTSV, CTSL | ITGB2 4458/4885ICAM1 3429/4885ITGAL 3821/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.